Endo International (NASDAQ:ENDP) Lifted to “Sell” at BidaskClub

BidaskClub upgraded shares of Endo International (NASDAQ:ENDP) (TSE:ENL) from a strong sell rating to a sell rating in a research note issued to investors on Friday, BidAskClub reports.

Several other research firms also recently commented on ENDP. ValuEngine raised shares of Endo International from a strong sell rating to a sell rating in a research note on Wednesday, October 2nd. Mizuho reissued a hold rating and set a $6.00 price target on shares of Endo International in a research note on Wednesday, August 7th. Royal Bank of Canada reissued a hold rating and set a $6.00 price target on shares of Endo International in a research note on Thursday, August 8th. Finally, Morgan Stanley set a $2.00 price target on shares of Endo International and gave the stock a sell rating in a research note on Friday, August 9th. Four investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have issued a buy rating to the stock. Endo International presently has a consensus rating of Hold and an average target price of $7.89.

Endo International stock traded up $0.04 during mid-day trading on Friday, hitting $4.88. 20,386,825 shares of the company traded hands, compared to its average volume of 8,649,315. Endo International has a one year low of $1.97 and a one year high of $18.25. The stock has a market cap of $1.09 billion, a price-to-earnings ratio of 1.69 and a beta of 1.33. The stock has a fifty day moving average price of $3.43 and a 200-day moving average price of $4.67.

Endo International (NASDAQ:ENDP) (TSE:ENL) last announced its earnings results on Monday, August 5th. The company reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.47 by $0.05. Endo International had a negative net margin of 19.98% and a negative return on equity of 129.30%. The business had revenue of $699.71 million during the quarter, compared to analyst estimates of $694.60 million. During the same period in the previous year, the business posted $0.76 earnings per share. Endo International’s revenue for the quarter was down 2.1% on a year-over-year basis. As a group, sell-side analysts forecast that Endo International will post 2.17 EPS for the current fiscal year.

In other Endo International news, Director Roger H. Kimmel sold 25,000 shares of Endo International stock in a transaction that occurred on Monday, September 16th. The shares were sold at an average price of $4.09, for a total transaction of $102,250.00. Following the transaction, the director now directly owns 123,309 shares of the company’s stock, valued at $504,333.81. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 1.50% of the company’s stock.

Several hedge funds and other institutional investors have recently modified their holdings of ENDP. Nordea Investment Management AB increased its stake in shares of Endo International by 37.5% in the first quarter. Nordea Investment Management AB now owns 177,700 shares of the company’s stock worth $1,427,000 after buying an additional 48,500 shares during the period. Arizona State Retirement System increased its stake in shares of Endo International by 1.4% in the second quarter. Arizona State Retirement System now owns 312,262 shares of the company’s stock worth $1,287,000 after buying an additional 4,167 shares during the period. Systematic Financial Management LP increased its stake in shares of Endo International by 63.4% in the second quarter. Systematic Financial Management LP now owns 193,380 shares of the company’s stock worth $797,000 after buying an additional 75,035 shares during the period. Meeder Asset Management Inc. increased its stake in shares of Endo International by 47.1% in the second quarter. Meeder Asset Management Inc. now owns 37,887 shares of the company’s stock worth $156,000 after buying an additional 12,127 shares during the period. Finally, Connor Clark & Lunn Investment Management Ltd. increased its stake in shares of Endo International by 61.2% in the second quarter. Connor Clark & Lunn Investment Management Ltd. now owns 3,063,703 shares of the company’s stock worth $12,622,000 after buying an additional 1,163,289 shares during the period. 95.78% of the stock is currently owned by institutional investors.

About Endo International

Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals.

Featured Article: Stock Selection – What is cash flow?

Analyst Recommendations for Endo International (NASDAQ:ENDP)

Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.